Skip to content

Welcome to Discover Pharma! Today is : November 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

biotech investment

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    INTREPID: Accelerating antiviral innovation for pandemic preparedness

    James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Vivodyne raises $40M to advance human tissue testing as alternative to animal models

    Vivodyne has secured $40 million in Series A funding to [...]

    May 5, 2026
Previous12

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Thalia reports early clinical activity for AML RNA therapy miRisten
    Categories: Advanced Therapies, Central Nervous System, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Sofinnova Partners closes €725m fund for European life sciences
    Categories: Biotech & Pharma Business, Drug Discovery & Development
  • Causaly launches AI platform to support scientific work across drug development
    Categories: Digital & Data
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top